Financial Performance - Q1 2024 total revenue reached $93.0 million, a 26% increase compared to $73.7 million in Q1 2023[8, 66] - Q1 2024 GAAP net loss improved to $17.0 million, a $2.9 million improvement year-over-year[5] - Q1 2024 adjusted EBITDA improved to $(1.7) million, a $11.0 million improvement compared to $(12.7) million in Q1 2023[5] - Operating cash flow for the trailing twelve months ended March 31, 2024, was $3.3 million, up from negative $13.2 million a year ago[11, 67, 86] Medicare Segment - Q1 2024 Medicare Advantage approved members increased 9% to 65,750 compared to 60,451 in Q1 2023[52] - Q1 '24 Medicare approved members increased 10% year-over-year[9] - Q1 '24 Medicare non-commission revenue was $11.6 million, with year-over-year growth of more than 100%[71] - Q1 2024 Medicare Advantage LTV increased 6% to $952 from $901 in Q1 2023[37] Amplify - Amplify annual gross margin target of 30%-35%[17] Guidance - The company reiterates its FY 2024 guidance, including total revenue of $450 million to $475 million, GAAP net loss of ($40) million to ($20) million, and adjusted EBITDA of ($5) million to $20 million[46]
eHealth(EHTH) - 2024 Q1 - Earnings Call Presentation